Question · asked by 1 review

ACT price vouchers vs no subsidies: ACT access (percentage of illness episodes treated with ACTs; all age groups)

What each review found

Include earlier review versions
FindingEffectStudiesGRADE certainty
ACT price vouchers vs no subsidies
ACT access (percentage of illness episodes treated with ACTs; all age groups) · Patients seeking treatment for suspected uncomplicated malaria
Subsidising artemisinin‐based combination therapy in the private retail sector (2016) · Cochrane Headline outcomes only
no estimate extracted1 study · 2789 participantsHigh

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Subsidising artemisinin‐based combination therapy in the private retail sector
2016 · Cochrane Headline outcomes only
Not reportedlist not extracted yetNot assessed

Studies behind the findings

None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.

How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.